INTRODUCTIONBreech presentation is the most common malpresentation. The incidence of breech presentation at term is 3-4%. Management of breech presentation at term is always being a topic of controversy. Day by day ECV is becoming a loosing Art. As delivery by Elective LSCS for Breech is associated with significantly lower neonatal mortality and morbidity, many obstetricians and pregnant women choose not to deliver breech babies vaginally. This is a significant contributing factor in increasing the caesarean rate and associated maternal morbidity.ECV has been definitely proven to decrease the incidence of breech at term.1 After rigorous scientific appraisal of several randomized controlled trials there has been renewed interest in external cephalic version in the last few years.2 American College of Obstetricians and Gynaecologists (2001) recommended that efforts should be made to reduce breech presentation by external cephalic version. 3 ABSTRACTBackground: Breech presentation is the most common malpresentation. The incidence of breech presentation at term is 3-4%. Objective of present study was to evaluate the outcome of external cephalic version (ECV) in singleton pregnancy with uncomplicated breech presentation at term in tertiary rural hospital and to analyze the immediate and ultimate outcome of external cephalic version done in term pregnancy with breech presentation with gestational age ≥37 weeks. Methods: This study was conducted at MIMER Medical college and BSTR Hospital, Talegaon Dabhade. Patients with breech presentation at term were studied over duration of 2½ years. 50 patients with breech presentation ≥37 weeks fulfilling the inclusion criteria underwent External cephalic version (ECV). Further obstetric progress is studied with the perinatal outcome and results were analyzed. Results: ECV was successful in 66% cases, out of which 88% cases had vaginal delivery and 12 % cases had LSCS for obstetric indication. Perinatal outcome was not affected with ECV. Conclusions: ECV at term significantly reduces both the incidence of breech delivery and caesarean section rate for breech delivery. ECV does not adversely affect the maternal and perinatal outcome.
Background: Incidence of twin pregnancy is increasing all over the world. It can occur after Assisted Reproductive Technology (ART) or spontaneously and associated with increased maternal and neonatal complications both in the developed and developing countries.Methods: A descriptive (Cross sectional) study of 64 cases of twins was undertaken between January 2013 till December 2015. Data collection was done prospectively from the patients admitted to the hospital with twin gestation. Inclusion criteria: All pregnancy with twin gestation more than 28 weeks of gestation. Twin pregnancies with both fetuses alive are included. Exclusion criteria is multiple gestation other than twins, cases with congenital malformation and intrauterine death (in one or both twins) were excluded. Data included thorough antenatal history, demographic details and intrapartum and postpartum maternal and neonatal details.Results: Prevalence of twins in our study was 1.61% (95% CI 1.3-2%). Out of 69 cases of twin pregnancy 64 cases fulfilled the inclusion criteria. History of ovulation induction was associated with 23% cases. Commonest complications observed were preterm labour (56.5%) anaemia (43.4%) and PIH (22.3%). 30.2% cases delivered vaginally whereas 69.8% patients required c. section, malpresentation being commonest indication. No intrapartum still birth was recorded. Early neonatal death was seen in eight cases, causes were prematurity, hyaline membrane disease and neonatal jaundice. Diamnoitic-dichorionic twins were 90% and 3% cases were monoamniotic monochorionic. Zygosity was calculated by Weinbergs formula and 84% cases were dizygotic while 16% cases were monozygotic. No maternal mortality related to twin pregnancy was reported in present study.Conclusions: All twin pregnancy should be considered as high risk pregnancies and should have mandatory hospital delivery. Early diagnosis, adequate antenatal, intrapartum and postpartum care as well as good NICU back up are the key factors in reducing the complications and improving the perinatal outcome in twin pregnancies.
BACKGROUND: The current maternal mortality rate of India is 212/100000 live births whereas the country's millennium development goal in this respect is 109/100000 live births by 2015. Although the progress has been made, the actual target remains far from sight. A step to achieve this goal would be to identify the factors affecting maternal mortality & curtail them. AIMS AND OBJECTIVE: To see the impact of BMI and number of ANC visits on mode of delivery baby weight and anaemia at term. So as to ensure that throughout pregnancy, the mother will have good health & that every pregnancy may culminate in healthy mother & healthy baby. STUDY SETTING: A tertiary care hospital attached to MIMER Medical College, Talegaon Dabhade, Pune. STUDY DESIGN: Community Based Cross-Sectional Study. MATERIALS AND METHODS: A suitable proforma was designed. Study design consisted of 342 pregnant women with singleton pregnancies. Inclusion criteria: Primigravida or multigravida with gestational age of >34 weeks & singleton pregnancies. DATA ANALYSIS AND STATISTICAL TESTS: Rates, Ratios, Proportions and Chi-square tests. CONCLUSION: BMI is a good indicator of nutrition in pregnant women. Females with good BMI has less chances of having LBW baby & have less chances of developing anaemia. Good amount of antenatal care leads to decrease in maternal & foetal mortality & morbidity. Though a minimum number of 3 visits are suggested, the study proves, minimum number of 5 visits is essential to decrease the LBW & anaemia incidence in mothers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.